Your dog was diagnosed with Oral Malignant Melanoma. Most common malignant oral tumour in dogs. Represents ~30-40% of oral malignancies. Highly aggressive with early metastasis to regional lymph nodes and lungs. Compare 5 treatment options for dogs including Surgical Excision (Mandibulectomy/Maxillectomy), Surgery + Adjuvant Carboplatin, Coarse-Fractionated (Hypofractionated) Radiation Therapy — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Oral Malignant Melanoma
Canine Oncology Treatment Guide
Oral Malignant Melanoma
WHO Stage I-IV
Melanocytic
About This Cancer
Oral malignant melanoma arises from melanocytes, the pigment-producing cells found in the lining of the mouth. It is the most common malignant tumour of the oral cavity in dogs and is among the most aggressive cancers encountered in canine oncology. The tumour can appear as a pigmented (dark) or amelanotic (non-pigmented) mass on the gums, palate, tongue, or lips. It typically invades underlying bone and spreads early to regional lymph nodes and lungs — by the time of diagnosis, metastasis has often already occurred. The WHO staging system, based on tumour size, is one of the strongest predictors of survival. Treatment usually involves aggressive surgery, often requiring partial removal of the jaw. A melanoma vaccine (Oncept) is available and is used as an adjunct to surgery and other treatments, though its precise survival benefit continues to be studied.
WHO Clinical Staging for Canine Oral Melanoma
Based on tumour diameter, lymph node involvement, and distant metastasis
Prognostic Factors(5)
Minimum Workup(6 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.